These Are The World’s Largest Drug And Biotech Companies

  • 📰 Forbes
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 53%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

As the coronavirus pandemic upends every facet of the global economy, Johnson & Johnson, Pfizer, and Cigna are leading the way.

in the first quarter thanks to higher demand. It pulled in $20.7 billion in sales last quarter for profits of $2.30 per share. In an earnings release, the company said that sales of consumer products like Tylenol and Zyrtec rose nearly 10% as consumers stocked up on over-the-counter drugs to reduce fever and other symptoms associated with COVID-19.

Johnson & Johnson, which has a market cap of $387 billion, announced in March that it has chosen a leading vaccine candidate for the virus; it anticipates starting human trials by September of this year. Chief scientific officer Paul Stoffels told ABC’s “The Week” that the company is aiming to deliver

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

Я верю в лучшее

Drug pushers. Yrumps beloved Dow needs speculative hype

How awesome that some companies are making huge monies on this COVID19 thingy... 🤑

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 394. in FR

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

PNC Financial to Exit Full Investment in BlackRockBlackRock's largest shareholder, PNC Financial, is exiting its roughly 22% stake in the firm, ending a lucrative wager on the world’s largest money manager Obvious. I may be stating the obvious, but announcing a huge sale at this uncertain time has a hint of desperation about it, compared with an offer to purchase. davidmwessel Unfolding. Let’s see the post sale impact on institutional vs non institutional in near to mid term horizon.
La source: WSJ - 🏆 98. / 63 Lire la suite »